Kiltearn Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,536,746
Closed -$32.8M 22
2016
Q2
$32.8M Sell
1,536,746
-3,527,300
-70% -$66.4M 1.48% 20
2016
Q1
$89.2M Sell
5,064,046
-13,454
-0.3% -$201K 3.76% 14
2015
Q4
$76.6M Sell
5,077,500
-158,400
-3% -$2.44M 3.73% 13
2015
Q3
$68.8M Buy
5,235,900
+1,341,500
+34% +$21.3M 3.19% 16
2015
Q2
$73.3M Buy
3,894,400
+264,200
+7% +$5.48M 3.4% 14
2015
Q1
$68.2M Buy
3,630,200
+1,390,600
+62% +$23.8M 3.66% 13
2014
Q4
$37.2M Buy
+2,239,600
New +$47.2M 2.41% 16
2014
Q2
Sell
-330,301
Closed -$10.5M 24
2014
Q1
$10.5M Sell
330,301
-469,200
-59% -$13M 1.1% 23
2013
Q4
$20.2M Buy
+799,501
New +$19.1M 3.38% 17

Other funds holding PTEN

Kiltearn Partners's PTEN Position: Q3 2016 in Review

Kiltearn Partners sold out of Patterson-UTI (PTEN) in Q3 2016, closing a stake of 1,536,746 shares — an estimated $32.8M sold.

Kiltearn Partners first reported a position in PTEN in Q4 2013 and held it in 9 quarters. The position peaked at $89.2M in Q1 2016. 274 funds tracked by Wall St. Rank hold PTEN as of Q3 2016.

  • Kiltearn Partners reported no remaining Patterson-UTI position as of Q3 2016 after selling out during the quarter.
  • Kiltearn Partners sold 1,536,746 Patterson-UTI shares in Q3 2016, an estimated $32.8M.
  • Kiltearn Partners first reported a position in Patterson-UTI in Q4 2013 and held it in 9 quarters.
  • Kiltearn Partners's Patterson-UTI position peaked at $89.2M in Q1 2016.
  • 274 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2016.

Based on Kiltearn Partners's 13F filing for Q3 2016, filed 10 Nov 2016.